37 related articles for article (PubMed ID: 18953252)
1. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Montuori N; Bifulco K; Carriero MV; La Penna C; Visconte V; Alfano D; Pesapane A; Rossi FW; Salzano S; Rossi G; Ragno P
Cell Mol Life Sci; 2011 Jul; 68(14):2453-67. PubMed ID: 20972812
[TBL] [Abstract][Full Text] [Related]
2. The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.
D'mello V; Singh S; Wu Y; Birge RB
J Biol Chem; 2009 Jun; 284(25):17030-17038. PubMed ID: 19383607
[TBL] [Abstract][Full Text] [Related]
3. Divalent cations modulate the integrin-mediated malignant phenotype in pancreatic cancer cells.
Grzesiak JJ; Bouvet M
Cancer Sci; 2008 Aug; 99(8):1553-63. PubMed ID: 18754866
[TBL] [Abstract][Full Text] [Related]
4. Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis.
Almaraz RT; Tian Y; Bhattarcharya R; Tan E; Chen SH; Dallas MR; Chen L; Zhang Z; Zhang H; Konstantopoulos K; Yarema KJ
Mol Cell Proteomics; 2012 Jul; 11(7):M112.017558. PubMed ID: 22457533
[TBL] [Abstract][Full Text] [Related]
5. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
Iakovlev V; Siegel ER; Tsao MS; Haun RS
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
[TBL] [Abstract][Full Text] [Related]
6. Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis.
George N; Bhandari P; Shruptha P; Jayaram P; Chaudhari S; Satyamoorthy K
Mol Cell Biochem; 2023 Nov; 478(11):2581-2606. PubMed ID: 36905477
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma.
Candido JB; Maiques O; Boxberg M; Kast V; Peerani E; Tomás-Bort E; Weichert W; Sananes A; Papo N; Magdolen V; Sanz-Moreno V; Loessner D
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439122
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer.
Du JP; Li L; Zheng J; Zhang D; Liu W; Zheng WH; Li XS; Yao RC; Wang F; Liu S; Tan X
Oncotarget; 2018 Feb; 9(16):12894-12906. PubMed ID: 29560118
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D
Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.
Xi S; Inchauste S; Guo H; Shan J; Xiao Z; Xu H; Miettenen M; Zhang MR; Hong JA; Raiji MT; Altorki NK; Casson AG; Beer DG; Robles AI; Bowman ED; Harris CC; Steinberg SM; Schrump DS
Oncogene; 2015 Oct; 34(44):5548-59. PubMed ID: 25703328
[TBL] [Abstract][Full Text] [Related]
11. Metastasis of ovarian cancer is mediated by kallikrein related peptidases.
Dong Y; Loessner D; Irving-Rodgers H; Obermair A; Nicklin JL; Clements JA
Clin Exp Metastasis; 2014 Jan; 31(1):135-47. PubMed ID: 24043563
[TBL] [Abstract][Full Text] [Related]
12. N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.
Hüttenhain R; Surinova S; Ossola R; Sun Z; Campbell D; Cerciello F; Schiess R; Bausch-Fluck D; Rosenberger G; Chen J; Rinner O; Kusebauch U; Hajdúch M; Moritz RL; Wollscheid B; Aebersold R
Mol Cell Proteomics; 2013 Apr; 12(4):1005-16. PubMed ID: 23408683
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
14. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.
Johnson SK; Ramani VC; Hennings L; Haun RS
Cancer; 2007 May; 109(9):1811-20. PubMed ID: 17354228
[TBL] [Abstract][Full Text] [Related]
16. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.
Madsen CD; Sidenius N
Eur J Cell Biol; 2008 Sep; 87(8-9):617-29. PubMed ID: 18353489
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy.
Mazar AP
Clin Cancer Res; 2008 Sep; 14(18):5649-55. PubMed ID: 18794071
[TBL] [Abstract][Full Text] [Related]
18. Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding.
Ramani VC; Haun RS
Pancreas; 2008 Nov; 37(4):399-404. PubMed ID: 18953252
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
